Search Results
Search results for "Ralf Jockers"
Results found for "Ralf Jockers"
Posts (22)
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its half-year
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
in dense receptor environments amplifies target occupancy, even post-clearance ✅ Insight into why half-life Why Half-Life Can Lie to You Most teams use systemic half-life as a proxy for action.
- Radioligands vs. Fluorescent Ligands: Binding Assays
The problem is their long half-life, which results in lower detection efficiency. Another common radioactive atom, 125I, with a higher specific activity, but a shorter half-life (60 days
Other Pages (8)
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
Ralf Jockers About Dr. Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from Ralf Jockers on the web Jockers Lab WGDR-3545 Pubmed Dr. GPCR Ecosystem Unlock the Full Dr.
- Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
path from neurobiology in Salzburg through academic labs in Vienna, Copenhagen, and Graz, to six and a half After running her own academic group in Graz, she spent six and a half years at Novo Nordisk in early
- Terry Kenakin: Allostery, Bias, and the Assays That Changed What We Could See | Dr. GPCR Ecosystem
Quantifying bias is the easy half. The body is the hard half.
